These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23437163)

  • 21. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y
    Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
    Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
    Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
    Chen JS; Su IJ; Leu YW; Young KC; Sun HS
    Int J Cancer; 2012 Mar; 130(6):1302-13. PubMed ID: 21469146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF
    Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma.
    Yu M; Han G; Qi B; Wu X
    Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
    PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA.
    Jin Y; Wu D; Yang W; Weng M; Li Y; Wang X; Zhang X; Jin X; Wang T
    Virol J; 2017 Dec; 14(1):238. PubMed ID: 29258558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rpb3 promotes hepatocellular carcinoma through its N-terminus.
    Fang ZP; Jiang BG; Zhang FB; Wang AD; Ji YM; Xu YF; Li JC; Zhou WP; Zhou WJ; Han HX
    Oncotarget; 2014 Oct; 5(19):9256-68. PubMed ID: 25211001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
    Han LL; Jia L; Wu F; Huang C
    Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma.
    Meng J; Sun B; Zhao X; Zhang D; Zhao X; Gu Q; Dong X; Zhao N; Liu P; Liu Y
    Mol Cancer Ther; 2014 Dec; 13(12):3107-22. PubMed ID: 25277383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma.
    Dayoub R; Wagner H; Bataille F; Stöltzing O; Spruss T; Buechler C; Schlitt HJ; Weiss TS
    Mol Med; 2011; 17(3-4):221-8. PubMed ID: 21152698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.